Skip to main content

Unbiased. Straight Facts.TM

Teva to pay $225M to settle cholesterol drug price-fixing charges

The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug.

Media Miss by the Right

See who else is reporting on this story and which side of the political spectrum they lean.

36 other sources covering this story

Total News Sources

36

Leaning Left

13

Center

12

Leaning Right

4

Last Updated

1 month ago

Bias Distribution

Left 45%

Center 41%

Right 14%

Click to see headlines

Far Left

+0

Left

+0

Far Right

+0

Bias Distribution Powered by Ground NewsTM

By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.